These terms apply when you access the Evidex website, evidence workspace, or a pilot integration. An organization's separate written agreement with the Evidex operator controls if it conflicts with these terms.
Evidex organizes reviewed sources into traceable evidence outputs for professional evaluation. It does not diagnose disease, prescribe treatment, determine eligibility, or replace clinical judgment. Users must independently review cited sources, current labels, trial records, patient context, and applicable rules before making a clinical or operational decision.
The public demo has a deliberately limited set of supported diseases, biomarkers, and variants. A result, missing result, rank, or summary must not be interpreted as a complete review of all available evidence.
You may use Evidex only for lawful professional evaluation and within the access granted to you. You must not:
Where account access is enabled, you are responsible for keeping credentials secure and for activity under your account. Notify your Evidex administrator or implementation lead promptly if you suspect unauthorized access.
Evidex software, presentation, and original product content are protected by applicable intellectual property laws. Underlying publications, labels, trial records, guidelines, and other third-party sources remain subject to their respective owners' terms and rights. Access to a citation through Evidex does not transfer rights in that source.
Pilot capabilities may change as coverage, evidence packages, and integration controls mature. Evidex may suspend access when reasonably necessary for maintenance, security, legal compliance, or protection of the service.
To the extent permitted by law, Evidex is provided on an as-available basis. Evidence can be incomplete, superseded, or affected by source availability. No warranty is made that an output is exhaustive or appropriate for a particular patient or purpose.
For questions about these terms, contact the Evidex administrator or implementation lead identified by your organization.
These terms may be updated as the product and deployment model mature. The date above identifies the current version. Continued use after an update constitutes acceptance where permitted by applicable law.